OVERVIEW

The Retina Radar With Dr. Arshad Khanani on GA Management and Targeting Lipids in AMD in 2025 is organized by Healio,Vindico Medical Education.

This enduring material is approved for 1 year from the date of original release, September 30, 2025, to September 29, 2026.

Description:
In these podcasts, expert clinicians will discuss available and emerging therapies for GA, including oral and systemic agents, as well as the potential therapies and rationale for targeting lipids to treat AMD. 

Learning Objectives:
Upon successful completion of this activity, participants should be better able to:

  • Examine how available and emerging therapies for GA can integrate into treatment paradigms to improve patient outcomes.
  • Summarize the latest data and clinical trial designs for oral and systemic treatments for GA.
  • Review treatments with novel mechanisms of action and supporting clinical data in managing retinal diseases.
Credits

Credits:
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

  • 1.25 CME
  • 1.25 AMA PRA Category 1 Credits™
  • TARGET AUDIENCE

    PhysicianOphthalmologist

    SPECIALITIES

    Ophthalmology

    RELATED ONLINE COURSES

    Webcast

    Ophthalmology
    2.5 AAPA
    More actions
    US$299

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910